Elegen’s new early access program intends to capture customer feedback to accelerate workflows across all industries relying on synthetic DNA, innovate its DNA products, and catalyze their adoption.
Shipments to members of the program already demonstrate a greater than two-fold leap in DNA length and advancements in manufacturing historically challenging, high-complexity sequences. We are definitely looking forward to working with them more in the future.”Įlegen launched their first product, ENFINIA™ DNA, in March, delivering customers NGS-verified DNA up to 7,000 base pairs long in 7 business days with error rates as low as 1:70,000 base pairs. They have produced multiple difficult sequences for us which we could not get from other sources as a single fragment.” Further adding, “In addition to a great success rate on their standard rapid turn product, they also produced several extremely difficult sequences with their new technology, including a construct containing a GS linker with an embedded repeat more than 50 bases long and another construct containing a region with >90% GC.
Alec Nielsen, Co-founder and CEO of Asimov, an existing early access partner, said, “We are extremely impressed with Elegen’s ability to produce DNA quickly, including difficult sequences. The company has also expanded the range of guanine-cytosine content accepted by 16%, going from a range of 16% - 80% to 8% - 88%.Īccess to longer double-stranded DNA enables Elegen’s early access partners to further reduce the cost and effort of producing long, multi-gene constructs without compromising the delivery time or DNA quality. For the new program, Elegen has expanded its synthesis acceptance criteria for repeat regions from 30 to 200 base pairs and hairpins from 25 to 60 base pairs.
NGU INDUSTRIES EARLY ACCESS FULL
The deliveries demonstrate Elegen’s commitment to continuously enhancing its DNA offering and empowering its customers to realize the full potential of synthetic biology.Įlegen’s early access partners can order DNA up to at least 15,000 base pairs long delivered in a plasmid and very complex sequences not readily accepted by other suppliers, including plasmid replication origins, promoters, inverted terminal repeats, and long terminal repeats. New early access program announced to gather customer requirements and accelerate workflows across pharma, agriculture, and chemical industriesĮlegen, a leader in DNA innovation, today announced the expedited delivery of high-complexity DNA sequences longer than 15,000 base pairs to members of their exclusive early access program. DNA lengths of 15,000 base pairs and higher represent twice the length of the Company’s recently launched flagship product, ENFINIA DNA, and industry-leading complexity and turnaround time
0 kommentar(er)
